Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
AQST
#2915
Aquestive Therapeutics, Inc. Common Stock
4.2
4
USD
+2.17%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.17%
Aylık Değişim
+5.21%
6 aylık değişim
-43.39%
Yıllık Değişim
+66.93%
Önceki Kapanış
4.1
5
Open
4.2
4
Bid
Ask
Low
4.2
4
High
4.2
4
Hacim
84
Piyasalar
ABD Borsası
Sağlık Hizmetleri
AQST
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
98.87 M
99.33 M
99.72 M
122 M
122.05 M
—
Valuation ratios
Enterprise value
402.46 M
269.76 M
319.79 M
603.04 M
838.38 M
2.03 B
Price to earnings ratio
-6.98
-5
-4.8
-7.99
-8.28
-26.06
Price to sales ratio
5.36
4.85
6.93
12.57
15.51
39.86
Price to cash flow ratio
-8.63
-5.5
-6.25
-10.88
-13.17
-35.8
Price to book ratio
-5.13
-1.31
-1.29
-2.66
-20.52
-25.78
Enterprise value to EBITDA ratio
-20.81
-9.09
-7.79
-13.64
-14.09
-44.61
Profitability ratios
Return on assets %
-0.17
-0.22
-0.14
-0.09
-0.2
-0.66
Return on equity %
0.28
0.38
0.19
3.76
0.95
5.27
Return on invested capital %
—
-413.66
-251.48
-231.62
—
—
Gross margin %
61.91
58.12
54.4
64.82
55.16
232.5
Operating margin %
-114.43
-222.08
-113.65
-89.63
-221.58
-646.94
EBITDA margin %
-89.78
-188.94
-84.77
-67.09
-199.46
-540.27
Net margin %
-143.72
-262.96
-135.44
-120.61
-244.79
-763.8
Liquidity ratios
Quick ratio
4.36
4.48
3.18
5.62
3.01
16.29
Current ratio
4.68
4.87
3.53
5.93
3.14
17.47
Inventory turnover
0.69
0.55
0.6
0.56
0.83
2.54
Asset turnover
0.11
0.09
0.1
0.1
0.08
0.37
Solvency ratios
Debt to assets ratio
0.5
0.49
0.54
0.31
0.31
1.65
Debt to equity ratio
-0.84
-0.83
-0.69
-12.19
-1.48
-15.2
Long term debt to total assets ratio
0.44
0.44
0.48
0.28
0.28
1.48
Long term debt to total equity ratio
-0.75
-0.74
-0.62
-10.95
-1.34
-13.65
Per share metrics
Operating cash flow per share
-0.07
-0.25
-0.08
-0.11
-0.08
-0.52
EBIT per share
-0.16
-0.2
-0.11
-0.1
-0.27
-0.69
EBITDA per share
-0.12
-0.17
-0.09
-0.08
-0.24
-0.58
Total debt per share
0.58
0.53
0.51
0.45
0.47
1.95
Cash per share
—
0.72
0.61
1.17
—
—
Net current asset value per share
1.02
0.93
0.82
1.37
1.4
4.52
Tangible book value per share
-0.69
-0.64
-0.73
-0.04
-0.31
-1.72
Working capital per share
0.8
0.74
0.59
1.14
0.95
3.42
Book value per share
-0.69
-0.64
-0.73
-0.04
-0.31
-1.72
Haberler
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Aquestive, Anaphylm için 2026 3. çeyrek NDA hedefini korudu
Aquestive, Thomas Zalewski’yi hukuk müdürü olarak atadı
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)
Aquestive Therapeutics İnsan Kaynakları Direktörü Boyd 124 bin dolarlık hisse sattı
Aquestive Therapeutics chief people officer Boyd sells $124k in stock
Aquestive Therapeutics CEO’su Barber 753.965 dolar hisse sattı
Aquestive Therapeutics hukuk müdürü 167 bin dolarlık hisse sattı
Aquestive Therapeutics SVP Cioffi 105 bin dolarlık hisse sattı
Aquestive Therapeutics CEO Barber sells $753,965 in stock
Aquestive Therapeutics SVP Cioffi sells $105k in shares
Aquestive therapeutics chief legal officer Braender sells $167k in stock